|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/551 | |
| A61K 31/7052 | |||
| A61K 31/7068 | |||
| A61K 31/706 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 2416781 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10713756.4 |
| Europos patento paraiškos padavimo data | 2010-04-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/030081 |
| Data | 2010-04-06 |
| (87) | Numeris | WO 2010/118013 |
| Data | 2010-10-14 |
| (30) | Numeris | Data | Šalis |
| 167117 P | 2009-04-06 | US |
| (72) |
BELYAKOV, Sergei, SG
DUVALL, Bridget, US
FERRARIS, Dana, US
HAMILTON, Gregory, US
VAAL, Mark, US
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | COMBINATION OF CYTIDINE-BASED ANTINEOPLASTIC DRUGS WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER |
| COMBINATION OF CYTIDINE-BASED ANTINEOPLASTIC DRUGS WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER |